Return to Full-bore Growth Strategy Risky for Taiyo Pharm

June 13, 2011
With the announcement of its acquisition by Teva Pharmaceutical Industries of Israel, Taiyo Pharmaceutical Industry has clearly set out to become the top generic drug maker in the domestic market. The founding family will sell all their shares to Teva...read more